D. E. Shaw & Co. Inc. boosted its position in shares of Rockwell Medical Inc (NASDAQ:RMTI) by 337.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 133,583 shares of the company’s stock after buying an additional 103,028 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.23% of Rockwell Medical worth $302,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the business. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Rockwell Medical in the 4th quarter valued at approximately $27,000. Starfire Investment Advisers Inc. acquired a new stake in shares of Rockwell Medical in the 4th quarter valued at approximately $43,000. AdvisorNet Financial Inc acquired a new stake in shares of Rockwell Medical in the 4th quarter valued at approximately $51,000. SG Americas Securities LLC acquired a new stake in shares of Rockwell Medical in the 4th quarter valued at approximately $75,000. Finally, Provident Investment Management Inc. boosted its stake in shares of Rockwell Medical by 50.0% in the 4th quarter. Provident Investment Management Inc. now owns 45,000 shares of the company’s stock valued at $102,000 after purchasing an additional 15,000 shares in the last quarter. Hedge funds and other institutional investors own 18.98% of the company’s stock.
A number of equities research analysts have recently weighed in on RMTI shares. ValuEngine downgraded shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Friday, March 1st. Ifs Securities upgraded shares of Rockwell Medical from an “outperform” rating to a “strong-buy” rating in a report on Monday, March 18th.
In other Rockwell Medical news, insider David S. Richmond acquired 5,869 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was acquired at an average price of $5.59 per share, for a total transaction of $32,807.71. Following the acquisition, the insider now directly owns 177,930 shares in the company, valued at $994,628.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 18.20% of the stock is owned by company insiders.
Shares of NASDAQ RMTI opened at $4.98 on Tuesday. The company has a market capitalization of $302.63 million, a P/E ratio of -10.60 and a beta of 2.12. Rockwell Medical Inc has a 1 year low of $2.19 and a 1 year high of $6.88.
Rockwell Medical (NASDAQ:RMTI) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.02). The business had revenue of $16.85 million during the quarter, compared to the consensus estimate of $16.10 million. Rockwell Medical had a negative net margin of 52.23% and a negative return on equity of 121.54%. On average, equities analysts expect that Rockwell Medical Inc will post -0.61 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “D. E. Shaw & Co. Inc. Has $302,000 Holdings in Rockwell Medical Inc (RMTI)” was first reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://transcriptdaily.com/2019/04/16/d-e-shaw-co-inc-has-302000-holdings-in-rockwell-medical-inc-rmti.html.
About Rockwell Medical
Rockwell Medical, Inc operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment.
Read More: What is the quiet period?
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.